Earnings Call · Q4 FY2021·2022-02-24

Q4 21EPS +5.26%·Rev n/aQ3 21EPS -1.06%·Rev n/aQ2 21EPS -22.94%·Rev n/aQ1 21EPS -18.83%·Rev n/a⚠ consensus missing

IMMUNIC, INC. IMUX

Company — N/A

Daniel Vitt — Chief Executive Officer, President & Director

Glenn Whaley — VP of Finance and Principal Financial & Accounting Officer

−9.2%1d on move date−10.7% vs SPY3d−1.3%5d+0.7%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more IMUX calls or request research access.

More IMUX calls Browse calls Request research access